This study also demonstrated significant interaction between regulatory genes of 11q23.3 region and intergenic APOA5-APOA4 protein coding genes to show distinct effects in manifesting CAD and dyslipidemia. This evidence concerns the gene APOA4 and metabolic syndrome.